Cooley Guides Adamas Pharma On $150M Follow-On
Cooley LLP is advising Adamas Pharmaceuticals Inc. on a $150 million stock offering, Adamas said Tuesday, adding to a busy year for Cooley's capital markets practice and bolstering its status as...To view the full article, register now.
Already a subscriber? Click here to view full article